August 2008

|
Volume 20 Issue 8
The AngioJet device has been shown to be a safe and effective device for mechanical thrombectomy, yet its association with severe bradyarrhythmia has impeded its broad acceptance and widespread use. This “brady effect” has forced physicians to temper…
How to Minimize the Need for Temporary Pacemaker during Rheolytic Thrombectomy ABSTRACT: Background. Whatever the mechanism or mechanisms involved in the genesis of bradyarrhythmias during rheolytic thrombectomy (RT), the severity and duration of br…
In Patients at High Risk for Symptomatic Bradycardia Undergoing AngioJet Mechanical Thrombectomy? ABSTRACT: We studied the feasibility and efficacy of glycopyrrolate, a synthetic anticholinergic agent with shorter half-life and without reflex tachyc…
ABSTRACT: Thrombectomy with the AngioJet® rheolytic thrombectomy catheter frequently causes bradyarrhythmias. This necessitates temporary pacemaker insertion and limits the device’s use. Novel approaches for treatment of bradyarrhythmias are being te…
ABSTRACT: In patients with acute ST elevation myocardial infarction or in those with thrombus-containing lesions, percutaneous coronary intervention (PCI) represents a clinical challenge to the interventionist, because coronary thrombus is a predicto…
Induced by Rheolytic Thrombectomy and Precludes the Need for Transvenous Pacing: The Scott & White Experience ABSTRACT: Rheolytic thrombectomy (RT) is useful in certain percutaneous coronary interventions but may be associated with transient bra…
ABSTRACT: The AngioJet® Rheolytic™ Thrombectomy System (Possis Medical, Inc., Minneapolis, Minnesota) is an effective thrombectomy device, but it may cause bradycardias ranging from mild bradycardia to asystole and hypotension in some patients. The i…
Primary percutaneous coronary intervention (PCI) is the preferred treatment for revascularizing infarct-related arteries in patients experiencing acute myocardial infarction (AMI). Thrombolytic occlusion of the coronary artery is the inciting event r…